Bullish recently completed a high-profile IPO and is positioned for growth with U.S. crypto market entry and crypto options ...

Elliott Investment Management has amassed a $4bn stake in PepsiCo and set out ways the US group can improve. Should the ...

These Ray-Ban Display glasses look high tech enough, but with the injection of AI comes serious privacy concerns, for both ...

Genpact (G) is executing a successful shift toward high-value, tech-led services, with Advanced Technology Solutions (ATS) ...

As a potential first-in-class, AI-designed oral GLP-1 receptor agonist (GLP-1RA), MDR-001 represents a breakthrough in drug discovery, demonstrating how AI can reshape traditional R&D pathways and ...

Telitacicept is approved in China for systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and generalized myasthenia gravis (gMG). A global Phase 3 clinical trial in gMG is currently ...

The executive who leads Intel’s business with the U.S. government said Tuesday that he has “made the difficult decision” to ...

MSU will host a DARPAConnect Regional Pop-Up on Wednesday, Sept. 24, from 8:30 a.m. to 4 p.m. in the Strand Union Building.

Featured presentations showcase the positive Phase 1 healthy volunteer trial results supporting KT-621’s oral, dupilumab-like profileKT-621 ...

The SCSUNAA celebrates alumni achievement at the Bulldog Excellence Awards, honoring Douglas D. Gantt, Renée N. Hamilton, and ...

Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced that ...